老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Propanc Biopharma, Inc.

0.6300
-0.0050-0.79%
盤前：0.64370.0137+2.17%04:12 EDT
成交量：44.98萬
成交額：30.05萬
市值：220.70萬
市盈率：-0.02
高：0.7321
開：0.6410
低：0.6290
收：0.6350
52周最高：57.00
52周最低：0.6253
股本：350.31萬
流通股本：125.01萬
量比：1.17
換手率：35.98%
股息：- -
股息率：- -
每股收益(TTM):-32.4560
每股收益(LYR):-371.2241
淨資產收益率：-126.98%
總資產收益率：-62.31%
市淨率：0.22
市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告
2020/06/26

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/13

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/04/03

重要事件披露

8-K - Current report
2020/02/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/02/11

SEC問詢函

CORRESP [Cover] - Correspondence
2020/01/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/01/17

重要事件披露

8-K - Current report
2019/12/12

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2019/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/10/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/10/08

重要事件披露

8-K - Current report
2019/09/09

重要事件披露

8-K - Current report
2019/08/06

重要事件披露

8-K - Current report
2019/07/10

重要事件披露

8-K - Current report
2019/07/01

重要事件披露

8-K - Current report
2019/06/21

重要事件披露

8-K - Current report
2019/06/20

SEC問詢函

CORRESP [Cover] - Correspondence
2019/06/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2019/05/30

重要事件披露

8-K - Current report
更多